A rare case of hypertrophic obstructive cardiomyopathy with mitral valve stenosis | |
DOI: 10.5606/e-cvsi.2016.353 | |
Anil Özen1, Aytaç Çalışkan2, Utku Ünal1, Emre Kubat3, Levent Birincioglu1 | |
1Department of Cardiovascular Surgery, Türkiye Yüksek İhtisas Training and Research Hospital, Ankara, Turkey 2Department of Cardiovascular Surgery, Karşıyaka State Hospital, İzmir, Turkey 3Department of Cardiovascular Surgery, Karabük University Karabük Training and Research Hospital, Karabük, Turkey |
|
Keywords: Hypertrophic obstructive cardiomyopathy; mitral stenosis; mitral valve replacement; septal myectomy | |
A 50-year-old male was referred with a 10 day history of tachypnea and dyspnea. Transthoracic echocardiography showed serious fibrotic
mitral stenosis and a mean gradient of 18 mmHg. The interventricular septum was hypertrophic with a width of 2.1 cm. A standard
septal myectomy and mitral valve replacement were performed. Hypertrophic obstructive cardiomyopathy is mostly associated with
mitral insufficiency rather than mitral stenosis. Surgery can be life-saving in acute deterioration in patients with coexisting hypertrophic
obstructive cardiomyopathy and mitral valve pathology. |
|
Hypertrophic obstructive cardiomyopathy (HOCM)
is a cause of sudden cardiac death in young patients.[1]
Intraventricular anatomical and contractile features
are the determinants of the clinical course and
management modality in most of the cases. Herein,
we discuss an unusual case of HOCM and mitral
stenosis (MS). |
|
CASE PRESANTATION
|
|
A 50-year-old male was referred to our hospital with
a 10-day history of tachypnea and dyspnea. Physical
examination revealed widespread crepitations at the
base of the lungs, particularly. His blood pressure
was 100/70 mmHg. Electrocardiography revealed
atrial flutter with a rate of 150 bpm. Transthoracic
echocardiography (TTE) demonstrated serious
fibrotic MS with a valve area of 1.2 cm2 and a mean
gradient of 18 mmHg. The interventricular septum
was hypertrophic with a width of 2.1 cm (Figure 1).
The pressure gradient of the left ventricular outflow
tract (LVOT) was 76 mmHg and the ejection fraction
was 60%. The preoperative TTE did not reveal an
abnormal anterior motion of the anterior leaflet.
Coronary angiography showed clinically insignificant
coronary plaques. Physical examination and a chest
X-ray revealed signs of pulmonary edema and increased
cardiothoracic ratio. A decision was made to operate
on an emergency basis. A written informed consent
was obtained from the patient. Transesophageal echocardiography probe was placed. Sternotomy was followed by bicaval cannulation. Cardiopulmonary bypass (CPB) was initiated. After cross-clamping, an oblique aortotomy was made towards the non-coronary sinus. The first incision was made to the subannular region at the level of the right and the left leaflet commissures. The second incision was made to the subannular region at the level of the right coronary ostium. These two incisions were adjoined with the third incision which was made 5 mm below the annulus. The myectomy was performed with a thickness of 1 cm and a length of 3-4 cm towards the apex. The myectomy was decided to be sufficient, when the trunk and the base of the papillary muscles became visible. As the mitral valve leaflets were severely thickened and fibrosed with a narrow valve orifice, the mitral valve replacement was performed. Transesophageal echocardiography revealed the pressure gradient of the LVOT as 15 mmHg and no systolic anterior motion (SAM) of the mitral valve was detected. The postoperative course was uneventful. He was followed in the intensive care unit (ICU) for two days and discharged in the eight postoperative day. |
|
Asymmetrical septal hypertrophy is the most common
cause of HOCM which results in SAM of the
anterior leaflet of the mitral valve.[2] This abnormal
movement of the mitral apparatus may also cause
mitral insufficiency and contributes to the worsening
of the left ventricular function.[3] Patients may
be asymptomatic, until the hypertrophy becomes
prominent and causes geometrical impairment of the
left ventricle.[1] Sudden cardiac death may be even the
presenting symptom in some of the cases.[1] The unusual presentation of our case is what makes this case interesting. Hypertrophic obstructive cardiomyopathy is mostly associated with mitral insufficiency rather than MS.[3] The preoperative TTE did not reveal an abnormal anterior motion of the anterior leaflet nor did we observe any regurgitation intraoperatively. There was a severe pressure gradient caused by the MS. The MS may have decreased the already low left ventricular filling even further. The clinical deterioration and pulmonary edema seen in our case, despite medical treatment, was due to the sum of the pathophysiological effects of HOCM and MS; HOCM increased the left ventricular end-diastolic pressure with outflow obstruction resulting in back pressure on the lungs, while MS caused dyspnea due to the restricted left ventricular inflow, thereby, resulting in left atrial pressure and back pressure on the pulmonary circulation. Pharmacological therapy with beta-blockers, calcium channel blockers, and disopyramide is often beneficial for patients with mild symptoms.[4] However, for patients refractory to the pharmacological therapy, more invasive therapeutic procedures can be lifesaving. In addition, alcohol-induced septal ablation (ASA) is an interventional treatment modality which aims to decrease the septal muscle mass.[5] Long-term follow-up results are comparable with surgical myectomy.[5] Alcohol-induced septal ablation can also achieve significant reduction of the LVOT obstruction gradient and symptomatic relief.[5] However, complications such as complete heart block are more common after ASA than surgical myectomy.[5] In daily practice, it is mostly performed in older patients with high surgical risk and in those without any intracardiac disease and not requiring open surgery.[5] Furthermore, surgery yields the best long-term results with good mortality and morbidity rates.[6] Septal myectomy is the conventional procedure in most of the cases.[7] Almost always, sufficient myectomy is achieved, if the papillary muscles are easily visible. Nevertheless, in some patients, myectomy may be insufficient in creating a wide outflow tract. In such cases, mitral valve replacement is the treatment of choice to relieve the LVOT obstruction.[7] In this case, mitral valve replacement was performed, as the mitral valve was not appropriate for repair. We believe that replacement of the valve also contributed to the abolition of the LVOT gradient.[8] In conclusion, in most cases, hypertrophic obstructive cardiomyopathy does not consist of a single anatomical pathology and it can manifest itself with an unusual clinical presentation, as in our case. Therefore, the approach to each case should be individualized and treatment decisions should be made by expert surgeons. Surgery is a more favorable approach for hypertrophic obstructive cardiomyopathy and can be life-saving in acute deterioration in patients with coexisting hypertrophic obstructive cardiomyopathy and mitral valve pathology.
Declaration of conflicting interests
Funding |
|
1) Maron BJ, Olivotto I, Spirito P, Casey SA, Bellone P, Gohman
TE, et al. Epidemiology of hypertrophic cardiomyopathyrelated
death: revisited in a large non-referral-based patient
population. Circulation 2000;102:858-64.
2) Wigle ED, Sasson Z, Henderson MA, Ruddy TD, Fulop
J, Rakowski H, et al. Hypertrophic cardiomyopathy. The
importance of the site and the extent of hypertrophy. A
review. Prog Cardiovasc Dis 1985;28:1-83.
3) Cavalcante JL, Barboza JS, Lever HM. Diversity of
mitral valve abnormalities in obstructive hypertrophic
cardiomyopathy. Prog Cardiovasc Dis 2012;54:517-22.
4) Nishimura RA, Holmes DR. Hypertrophic obstructive
cardiomyopathy. N Engl J Med 2004;350:1320-7.
5) Yavuzgil O, Tülüce K, Şimşek E, Gürgün C, Kültürsay H,
Payzın S ve ark. Hipertrofik obstrüktif kardiyomiyopatide
septal alkol ablasyonu: Retrospektif bir inceleme. Turk
Gogus Kalp Dama 2012;20:427-33.
6) Ünal EU, Özen A, İşcan HZ, Birincioğlu CL. Obstrüktif
hipertrofik kardiyomiyopatide cerrahi tedavinin erken
ve orta dönem sonuçları. Turk Gogus Kalp Dama
2012;20:421-6.
|
|